Eli Lilly and Company
(E)-1-(4-(DIMETHYLAMINO)BUT-2-ENOYL)PYRROLIDIN-3-YL 4-((3-ISOPROPYL-5-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-7-YL)AMINO)PIPERIDINE-1-- CARBOXYLATE FOR INHIBITING CDK7
Last updated:
Abstract:
The present invention provides novel CDK7 inhibitors and pharmaceutical compositions thereof: ##STR00001## or a pharmaceutically acceptable salt thereof.
Status:
Application
Type:
Utility
Filling date:
22 Sep 2020
Issue date:
4 Feb 2021